Deep Brain Stimulation at Some Frequencies May Be as Effective as Medication for Parkinson’s Disease
A new study offers hope for improving DBS treatments.
In 2021, scientists continue to learn about diagnosis, treatment and prevention of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Three new studies show protein biomarkers can identify Alzheimer’s Disease years before people have symptoms.
Researchers have discovered nontraditional techniques to identify Parkinson’s disease as early as possible, offering hope for patients seeking answers during the early stages of this difficult-to-diagnose neurological condition.
Researchers with Rice University develop the first neural stimulator powered by magnetic energy.
Alzheimer’s disease, irritable bowel disease and osteoarthritis place a heavy burden on patients, caregivers and the healthcare system.
Ischemic stroke and transient ischemic attack (TIA) have grown more prevalent in young and middle-aged adults during the past decade. According to research led by the University of North Carolina School of Medicine, post-traumatic stress disorder may be to blame.
A dearth of therapies to repair spinal cord damage and reverse paralysis following spinal cord injury spurred a team of researchers to embark on an ambitious project to map the spine as never before.
Although many neurological health conditions are common to both women and men, symptoms can manifest in distinct ways for women. These considerations may impact the diagnosis and treatment of seemingly non-sex-specific medical conditions in women.
Recent scientific advances point to a hopeful future for people who have or could develop Parkinson’s disease, according to a review published in the Journal of Parkinson’s Disease.
- 1 of 7
- next ›